Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16373195 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Alternative in Beta Blocker Intolerance: The ABBI Trial
Condition: Coronary Artery Disease
Intervention: Drug: Nebivolol

Indicates status has not been verified in more than two years